Clin2
NCT07139405Likely a fitNot yet recruiting

New drug vs metformin for weight and diabetes control

Type 2 Diabetes (T2DM)

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial compares a new drug, TriGlytza-01, to metformin in people with type 2 diabetes who are overweight or obese and whose blood sugar isn't well controlled despite taking metformin. The goal is to see if the new drug works better at improving blood sugar and weight.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
48 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have been diagnosed with type 2 diabetes.
  • You are currently taking metformin but your blood sugar is still too high.
  • Your Body Mass Index (BMI) is between 25 and 40.
  • You have not had weight-loss surgery or taken weight-loss drugs recently.
  • You do not have serious kidney, liver, heart, or other major health problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06888050Recruiting· Phase 4
Study of new diabetes pill versus metformin for new type 2 diabetes

This trial tests a new combination pill (henagliflozin and metformin) compared to metformin alone in people recently diagnosed with type 2 diabetes. The goal is to see which treatment works better and is safer.

Hangzhou, Zhejiang
NCT07311551Not yet recruiting· Phase 4
Comparing two diabetes drugs for weight management

This trial compares two medications, dapagliflozin and empagliflozin, to see which works better and is safer for people with type 2 diabetes and a high body mass index (BMI). If you are an adult with type 2 diabetes and a BMI of 23 or higher, this study might help find a treatment that also supports weight loss.

NCT06670209Not yet recruiting· Phase 1
Drug interaction study for weight management medication

This study tests how a new injectable weight loss drug affects the way the body processes metformin, a common diabetes medication. It is for Chinese adults who are overweight or obese.

NCT06246799Recruiting· Phase 3
Comparing two pill combinations for new diabetes

This study compares two different two-drug combinations for people recently diagnosed with type 2 diabetes. It aims to find which combination works better to control blood sugar and improve overall health.

San Antonio, Texas
NCT07244003Recruiting· Phase 4
Testing metformin with two newer diabetes drugs

This trial is testing if adding a combination of SGLT-2 inhibitor and GLP-1 receptor agonist to metformin can improve blood sugar control in people with type 2 diabetes who are not meeting their goals on metformin alone or with one other pill.

Tianjin, Tianjin Municipality
NCT07533175Recruiting· Phase 3
Testing a new weight-loss medicine for type 2 diabetes

This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.

Birmingham, Alabama

Hear when a new Type 2 Diabetes (T2DM) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.